#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Kitty Yale Email
EVP and Chief Development Officer . Akero Therapeutics
South San Francisco, CA
LocationPrimary Email
How to contact Kitty Yale
Join and see Kitty's contact info for free!Current Roles
Employees:
72Revenue:
$5.4MAbout
Akero Therapeutics is developing best-in-class medicines that restore metabolic balance to treat non-alcoholic steatohepatitis (NASH) and other serious metabolic diseases. Akero's lead clinical program, AKR-001, is a long-acting Fc fusion modified FGF21 protein and potential best-in-class treatment for NASH. AKR-001 builds upon two decades of work on FGF21 biology. It is designed to affect both the liver and adipose tissue, reducing liver fat and suppressing inflammation and fibrosis.Akero Therapeutics Address
601 Gateway BoulevardSouth San Francisco, CA
United States